Icure Pharmaceutical Incorporation Capital Reinvestment Ratio
Icure Pharmaceutical Incorporation capital reinvestment ratio. Icure Pharmaceutical Incorporation (175250) has a Capital Reinvestment Ratio of 38.07x as of June 2020, meaning it reinvests 38% of its operating cash flow (₩195.44 Million) in capital expenditures (₩7.44 Billion). Check 175250 capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Icure Pharmaceutical Incorporation (2017–2017)
Capital reinvestment ratio of Icure Pharmaceutical Incorporation from 2017 to 2017. This chart tracks Icure Pharmaceutical Incorporation's Capital Reinvestment Ratio across 1 annual periods. Also explore Icure Pharmaceutical Incorporation equity growth rate to track the company's year-over-year net asset growth rate.
Icure Pharmaceutical Incorporation Capital Reinvestment Ratio by Year (2017–2017)
Icure Pharmaceutical Incorporation capital reinvestment ratio by year from 2017 to 2017. For the full cash flow conversion analysis, see how efficiently does Icure Pharmaceutical Incorporation generate cash.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2017 | 9.02x | ₩1.12 Billion | ₩10.10 Billion | — |